{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:48:32Z","timestamp":1792324112433,"version":"4.4.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00213-024-06569-x","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T15:03:47Z","timestamp":1709737427000},"page":"875-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A systematic review and meta-analysis of synthetic cathinone use and psychosis"],"prefix":"10.1007","volume":"241","author":[{"given":"Rishika R.","family":"Daswani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.","family":"Choles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair M.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"issue":"9\u201310","key":"6569_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00213-017-4551-7","volume":"234","author":"PD Alexander","year":"2017","unstructured":"Alexander PD, Gicas KM, Willi TS, Kim CN, Boyeva V, Procyshyn RM, Smith GN, Thornton AE, Panenka WJ, Jones AA, Vila-Rodriguez F, Lang DJ, William MacEwan G, Honer WG, Barr AM (2017) A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence. Psychopharmacology 234(9\u201310):1535\u20131547. https:\/\/doi.org\/10.1007\/s00213-017-4551-7","journal-title":"Psychopharmacology"},{"key":"6569_CR2","doi-asserted-by":"publisher","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https:\/\/doi.org\/10.1176\/appi.books.9780890425596","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"6569_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/15563650.2014.981823","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Lindeman E, Beck O, Helander A (2015) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (phila) 53(1):46\u201353. https:\/\/doi.org\/10.3109\/15563650.2014.981823","journal-title":"Clin Toxicol (phila)"},{"issue":"1\u20132","key":"6569_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0091-3057(01)00664-5","volume":"71","author":"AM Barr","year":"2002","unstructured":"Barr AM, Phillips AG (2002) Increased successive negative contrast in rats withdrawn from an escalating-dose schedule of D-amphetamine. Pharmacol Biochem Behav 71(1\u20132):293\u2013299 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11812535)","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"6569_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.20882\/adicciones.824","volume":"28","author":"P Barrio","year":"2016","unstructured":"Barrio P, Gaskell M, Goti J, Vilardell S, F\u00e0bregas JM (2016) Persistent psychotic symptoms after long-term heavy use of mephedrone: A two-case series. Adicciones 28(3):154\u2013157. https:\/\/doi.org\/10.20882\/adicciones.824","journal-title":"Adicciones"},{"issue":"10","key":"6569_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/add.12601","volume":"109","author":"MH Baumann","year":"2014","unstructured":"Baumann MH (2014) Awash in a sea of \u201cbath salts\u201d: implications for biomedical research and public health. Addiction 109(10):1577\u20131579. https:\/\/doi.org\/10.1111\/add.12601","journal-title":"Addiction"},{"issue":"5","key":"6569_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/npp.2011.304","volume":"37","author":"MH Baumann","year":"2012","unstructured":"Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, Brandt SD, Rothman RB, Ruoho AE, Cozzi NV (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37(5):1192\u20131203. https:\/\/doi.org\/10.1038\/npp.2011.304","journal-title":"Neuropsychopharmacology"},{"key":"6569_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/164_2018_178","volume":"252","author":"MH Baumann","year":"2018","unstructured":"Baumann MH, Walters HM, Niello M, Sitte HH (2018) Neuropharmacology of synthetic cathinones. Handb Exp Pharmacol 252:113\u2013142. https:\/\/doi.org\/10.1007\/164_2018_178","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"6569_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","volume":"53","author":"O Beck","year":"2015","unstructured":"Beck O, Franzen L, B\u00e4ckberg M, Signell P, Helander A (2015) Intoxications involving MDPV in Sweden during 2010\u20132014: Results from the STRIDA project. Clin Toxicol (phila) 53(9):865\u2013873. https:\/\/doi.org\/10.3109\/15563650.2015.1089576","journal-title":"Clin Toxicol (phila)"},{"issue":"4","key":"6569_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/15563650.2017.1370097","volume":"56","author":"O Beck","year":"2018","unstructured":"Beck O, B\u00e4ckberg M, Signell P, Helander A (2018) Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives. MDPV Copycats Clin Toxicol (phila) 56(4):256\u2013263. https:\/\/doi.org\/10.1080\/15563650.2017.1370097","journal-title":"MDPV Copycats Clin Toxicol (phila)"},{"issue":"12","key":"6569_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1080\/15563650.2021.1909730","volume":"59","author":"G Blanco","year":"2021","unstructured":"Blanco G, Vidler D, Roper C, Wood DM, Dargan PI, Keating L, Macfarlane R, Emmett S, Johnson G, Eddleston M, Hill SL, Thomas SHL (2021) Acute toxicity from the synthetic cathinone N-ethylpentylone (ephylone) in the United Kingdom. Clin Toxicol (phila) 59(12):1270\u20131273. https:\/\/doi.org\/10.1080\/15563650.2021.1909730","journal-title":"Clin Toxicol (phila)"},{"issue":"3","key":"6569_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.neuropharm.2011.02.019","volume":"62","author":"HN Boyda","year":"2012","unstructured":"Boyda HN, Procyshyn RM, Tse L, Wong D, Pang CC, Honer WG, Barr AM (2012) Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats. Neuropharmacology 62(3):1391\u20131400 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21376062)","journal-title":"Neuropharmacology"},{"issue":"7","key":"6569_CR13","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","volume":"239","author":"SC Britch","year":"2022","unstructured":"Britch SC, Walsh SL (2022) Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology 239(7):2063\u20132081. https:\/\/doi.org\/10.1007\/s00213-022-06125-5","journal-title":"Psychopharmacology"},{"issue":"1","key":"6569_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/09687637.2016.1192106","volume":"24","author":"F Brookman","year":"2017","unstructured":"Brookman F, Bennett TH, Hills R (2017) The pleasures and pains of mephedrone use: Perceptions of users and practitioners. Drugs: Education, Prevention and Policy 24(1):103\u2013110. https:\/\/doi.org\/10.1080\/09687637.2016.1192106","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"6569_CR15","unstructured":"Canada Border Services Agency (2023) Government of Canada. Retrieved 2023 Jul 13 from: https:\/\/www.cbsa-asfc.gc.ca\/security-securite\/seizure-saisie-eng.html"},{"key":"6569_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/cpaa.s42832","volume":"5","author":"M Capriola","year":"2013","unstructured":"Capriola M (2013) Synthetic cathinone abuse. Clin Pharmacol 5:109\u2013115. https:\/\/doi.org\/10.2147\/cpaa.s42832","journal-title":"Clin Pharmacol"},{"issue":"9","key":"6569_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1177\/0960327121996043","volume":"40","author":"HH Chou","year":"2021","unstructured":"Chou HH, Hsieh CH, Chaou CH, Chen CK, Yen TH, Liao SC, Seak CJ, Chen HY (2021) Synthetic cathinone poisoning from ingestion of drug-laced \u201cinstant coffee packets\u201d in Taiwan. Hum Exp Toxicol 40(9):1403\u20131412. https:\/\/doi.org\/10.1177\/0960327121996043","journal-title":"Hum Exp Toxicol"},{"key":"6569_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fpsyt.2018.00662","volume":"9","author":"SR Clark","year":"2018","unstructured":"Clark SR, Schubert KO, Olagunju AT, Lyrtzis EA, Baune BT (2018) Cognitive and functional assessment of psychosis stratification study (CoFAPSS): rationale, design, and characteristics. Front Psychiatry 9:662. https:\/\/doi.org\/10.3389\/fpsyt.2018.00662","journal-title":"Front Psychiatry"},{"issue":"4","key":"6569_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/02791072.2014.944291","volume":"46","author":"O Corazza","year":"2014","unstructured":"Corazza O, Valeriani G, Bersani FS, Corkery J, Martinotti G, Bersani G, Schifano F (2014) \u201cSpice,\u201d \u201ckryptonite,\u201d \u201cblack mamba\u201d: an overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs 46(4):287\u2013294. https:\/\/doi.org\/10.1080\/02791072.2014.944291","journal-title":"J Psychoactive Drugs"},{"key":"6569_CR20","doi-asserted-by":"publisher","first-page":"640222","DOI":"10.3389\/fpsyt.2021.640222","volume":"12","author":"CE Crocker","year":"2021","unstructured":"Crocker CE, Carter AJE, Emsley JG, Magee K, Atkinson P, Tibbo PG (2021) When cannabis use goes wrong: mental health side effects of cannabis use that present to emergency services. Front Psychiatry 12:640222. https:\/\/doi.org\/10.3389\/fpsyt.2021.640222","journal-title":"Front Psychiatry"},{"issue":"11","key":"6569_CR21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/qjmed\/hcq134","volume":"103","author":"PI Dargan","year":"2010","unstructured":"Dargan PI, Albert S, Wood DM (2010) Mephedrone use and associated adverse effects in school and college\/university students before the UK legislation change. QJM 103(11):875\u2013879. https:\/\/doi.org\/10.1093\/qjmed\/hcq134","journal-title":"QJM"},{"issue":"1","key":"6569_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.toxac.2016.11.005","volume":"29","author":"A Daveluy","year":"2017","unstructured":"Daveluy A, Labadie M, Titier K, Courtois A, Penouil F, Castaing N, Haramburu F, Faure I, Cazanave C, Delile J, Latour V, Valdenaire G (2017) Poisoning by synthetic cathinones: Consumption behaviour and clinical description from 11 cases recorded by the Addictovigilance Centre of Bordeaux. Toxicologie Analytique Et Clinique 29(1):34\u201340. https:\/\/doi.org\/10.1016\/j.toxac.2016.11.005","journal-title":"Toxicologie Analytique Et Clinique"},{"issue":"1","key":"6569_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2013.10.029","volume":"97","author":"LJ De Felice","year":"2014","unstructured":"De Felice LJ, Glennon RA, Negus SS (2014) Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology. Life Sci 97(1):20\u201326. https:\/\/doi.org\/10.1016\/j.lfs.2013.10.029","journal-title":"Life Sci"},{"key":"6569_CR24","unstructured":"Deeks JJ, Higgins JPT, Altman DG\u00a0(editors) (2023)\u00a0Chapter 10: analysing data and undertaking meta-analyses. In: JPT Higgins, J Thomas, J Chandler, M Cumpston, T Li, MJ Page, VA Welch (eds) Cochrane handbook for systematic reviews of interventions\u00a0version 6.4 (updated August 2023). Cochrane. Available from www.training.cochrane.org\/handbook"},{"key":"6569_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.forsciint.2017.12.003","volume":"283","author":"M Diestelmann","year":"2018","unstructured":"Diestelmann M, Zangl A, Herrle I, Koch E, Graw M, Paul LD (2018) MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. Forensic Sci Int 283:72\u201384. https:\/\/doi.org\/10.1016\/j.forsciint.2017.12.003","journal-title":"Forensic Sci Int"},{"issue":"12","key":"6569_CR26","doi-asserted-by":"publisher","first-page":"e0225273","DOI":"10.1371\/journal.pone.0225273","volume":"14","author":"L Elliott","year":"2019","unstructured":"Elliott L, Haddock CK, Campos S, Benoit E (2019) Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities. PLoS One 14(12):e0225273. https:\/\/doi.org\/10.1371\/journal.pone.0225273","journal-title":"PLoS One"},{"key":"6569_CR27","doi-asserted-by":"publisher","first-page":"694863","DOI":"10.3389\/fpsyt.2021.694863","volume":"12","author":"A Fiorentini","year":"2021","unstructured":"Fiorentini A, Cant\u00f9 F, Crisanti C, Cereda G, Oldani L, Brambilla P (2021) Substance-induced psychoses: an updated literature review. Front Psychiatry 12:694863. https:\/\/doi.org\/10.3389\/fpsyt.2021.694863","journal-title":"Front Psychiatry"},{"key":"6569_CR28","doi-asserted-by":"publisher","first-page":"110626","DOI":"10.1016\/j.pnpbp.2022.110626","volume":"120","author":"Z Fi\u0161ar","year":"2023","unstructured":"Fi\u0161ar Z (2023) Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 120:110626. https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110626","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"6569_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00952990.2012.677890","volume":"38","author":"MB Forrester","year":"2012","unstructured":"Forrester MB (2012) Synthetic cathinone exposures reported to Texas poison centers. Am J Drug Alcohol Abuse 38(6):609\u2013615. https:\/\/doi.org\/10.3109\/00952990.2012.677890","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"6569_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PEC.0b013e3182808ae2","volume":"29","author":"MB Forrester","year":"2013","unstructured":"Forrester MB (2013) Adolescent synthetic cathinone exposures reported to Texas poison centers. Pediatr Emerg Care 29(2):151\u2013155. https:\/\/doi.org\/10.1097\/PEC.0b013e3182808ae2","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"6569_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1176\/appi.ajp.2021.21111126","volume":"179","author":"S Ganesh","year":"2022","unstructured":"Ganesh S, D\u2019Souza DC (2022) Cannabis and psychosis: recent epidemiological findings continuing the \u201cCausality Debate.\u201d Am J Psychiatry 179(1):8\u201310. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21111126","journal-title":"Am J Psychiatry"},{"key":"6569_CR32","doi-asserted-by":"publisher","first-page":"859563","DOI":"10.3389\/fphar.2022.859563","volume":"13","author":"HM Hazani","year":"2022","unstructured":"Hazani HM, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya MF, Teoh SL, Pakri Mohamed RM, Mohamad Isa MF, Abdulrahman SM, Ramadah R, Kamaluddin MR, Kumar J (2022) Goofballing of opioid and methamphetamine: the science behind the deadly cocktail. Front Pharmacol 13:859563. https:\/\/doi.org\/10.3389\/fphar.2022.859563","journal-title":"Front Pharmacol"},{"issue":"7","key":"6569_CR33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0706743717693781","volume":"62","author":"WG Honer","year":"2017","unstructured":"Honer WG, Cervantes-Larios A, Jones AA, Vila-Rodriguez F, Montaner JS, Tran H, Nham J, Panenka WJ, Lang DJ, Thornton AE, Vertinsky T, Barr AM, Procyshyn RM, Smith GN, Buchanan T, Krajden M, Krausz M, MacEwan GW, Gicas KM, Leonova O, Langheimer V, Rauscher A, Schultz K (2017) The hotel study-clinical and health service effectiveness in a cohort of homeless or marginally housed persons. Can J Psychiatry 62(7):482\u2013492. https:\/\/doi.org\/10.1177\/0706743717693781","journal-title":"Can J Psychiatry"},{"issue":"2","key":"6569_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/cpt.575","volume":"101","author":"MA Huestis","year":"2017","unstructured":"Huestis MA, Tyndale RF (2017) Designer drugs 2.0. Clin Pharmacol Ther 101(2):152\u2013157. https:\/\/doi.org\/10.1002\/cpt.575","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"6569_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.drugpo.2012.03.006","volume":"23","author":"E Hyshka","year":"2012","unstructured":"Hyshka E, Strathdee S, Wood E, Kerr T (2012) Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research. Int J Drug Policy 23(4):261\u2013270. https:\/\/doi.org\/10.1016\/j.drugpo.2012.03.006","journal-title":"Int J Drug Policy"},{"key":"6569_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"14","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF (2014) The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol 14:25. https:\/\/doi.org\/10.1186\/1471-2288-14-25","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"6569_CR37","doi-asserted-by":"publisher","first-page":"e008876","DOI":"10.1136\/bmjopen-2015-008876","volume":"5","author":"AA Jones","year":"2015","unstructured":"Jones AA, Vila-Rodriguez F, Leonova O, Langheimer V, Lang DJ, Barr AM, Procyshyn RM, Smith GN, Schultz K, Buchanan T, Krausz M, Montaner JS, MacEwan GW, Rauscher A, Panenka WJ, Thornton AE, Honer WG (2015) Mortality from treatable illnesses in marginally housed adults: a prospective cohort study. BMJ Open 5(8):e008876. https:\/\/doi.org\/10.1136\/bmjopen-2015-008876","journal-title":"BMJ Open"},{"issue":"12","key":"6569_CR38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/0269881116653106","volume":"30","author":"L Jones","year":"2016","unstructured":"Jones L, Reed P, Parrott A (2016) Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users. J Psychopharmacol 30(12):1313\u20131320. https:\/\/doi.org\/10.1177\/0269881116653106","journal-title":"J Psychopharmacol"},{"issue":"3","key":"6569_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamapsychiatry.2017.4432","volume":"75","author":"AA Jones","year":"2018","unstructured":"Jones AA, Jang K, Panenka WJ, Barr AM, MacEwan GW, Thornton AE, Honer WG (2018) Rapid change in fentanyl prevalence in a community-based. High-Risk Sample JAMA Psychiatry 75(3):298\u2013300. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4432","journal-title":"High-Risk Sample JAMA Psychiatry"},{"issue":"7","key":"6569_CR40","doi-asserted-by":"publisher","first-page":"e1003172","DOI":"10.1371\/journal.pmed.1003172","volume":"17","author":"AA Jones","year":"2020","unstructured":"Jones AA, Gicas KM, Seyedin S, Willi TS, Leonova O, Vila-Rodriguez F, Procyshyn RM, Smith GN, Schmitt TA, Vertinsky AT, Buchanan T, Rauscher A, Lang DJ, MacEwan GW, Lima VD, Montaner JSG, Panenka WJ, Barr AM, Thornton AE, Honer WG (2020) Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver. Canada Plos Med 17(7):e1003172. https:\/\/doi.org\/10.1371\/journal.pmed.1003172","journal-title":"Canada Plos Med"},{"issue":"21","key":"6569_CR41","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2169\/internalmedicine.53.2344","volume":"53","author":"Y Kamijo","year":"2014","unstructured":"Kamijo Y, Takai M, Fujita Y, Hirose Y, Iwasaki Y, Ishihara S, Yokoyama T, Yagi K, Sakamoto T (2014) A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med 53(21):2439\u20132445. https:\/\/doi.org\/10.2169\/internalmedicine.53.2344","journal-title":"Intern Med"},{"issue":"4","key":"6569_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/hup.2297","volume":"28","author":"M Kapit\u00e1ny-F\u00f6v\u00e9ny","year":"2013","unstructured":"Kapit\u00e1ny-F\u00f6v\u00e9ny M, Kert\u00e9sz M, Winstock A, Deluca P, Corazza O, Farkas J, Zacher G, Urb\u00e1n R, Demetrovics Z (2013) Substitutional potential of mephedrone: an analysis of the subjective effects. Hum Psychopharmacol 28(4):308\u2013316. https:\/\/doi.org\/10.1002\/hup.2297","journal-title":"Hum Psychopharmacol"},{"key":"6569_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2020.00037","volume":"14","author":"M Kapit\u00e1ny-F\u00f6v\u00e9ny","year":"2020","unstructured":"Kapit\u00e1ny-F\u00f6v\u00e9ny M, Kiss A, Farkas J, Kuczora KE, Pataki P, Horv\u00e1th J, Demetrovics Z (2020) Childhood trauma, cognitive emotion regulation and motivation for behavior change among clients of opioid substitution treatment with and without past year synthetic cathinone use during therapy. Front Neurosci 14:37. https:\/\/doi.org\/10.3389\/fnins.2020.00037","journal-title":"Front Neurosci"},{"key":"6569_CR44","doi-asserted-by":"publisher","unstructured":"Kapit\u00e1ny-F\u00f6v\u00e9ny M, Farkas J, Pataki PA, Kiss A, Horv\u00e1th J, Urb\u00e1n R, Demetrovics Z (2017) Novel psychoactive substance use among treatment-seeking opiate users: The role of life events and psychiatric symptoms. Hum Psychopharmacol 32(3). https:\/\/doi.org\/10.1002\/hup.2602","DOI":"10.1002\/hup.2602"},{"issue":"1","key":"6569_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1570159x13666141210224137","volume":"13","author":"L Karila","year":"2015","unstructured":"Karila L, Megarbane B, Cottencin O, Lejoyeux M (2015) Synthetic cathinones: a new public health problem. Curr Neuropharmacol 13(1):12\u201320. https:\/\/doi.org\/10.2174\/1570159x13666141210224137","journal-title":"Curr Neuropharmacol"},{"key":"6569_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","volume":"194","author":"JY Khokhar","year":"2018","unstructured":"Khokhar JY, Dwiel LL, Henricks AM, Doucette WT, Green AI (2018) The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophr Res 194:78\u201385. https:\/\/doi.org\/10.1016\/j.schres.2017.04.016","journal-title":"Schizophr Res"},{"issue":"1","key":"6569_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11419-022-00639-5","volume":"41","author":"P Kuropka","year":"2023","unstructured":"Kuropka P, Zawadzki M, Szpot P (2023) A review of synthetic cathinones emerging in recent years (2019\u20132022). Forensic Toxicol 41(1):25\u201346. https:\/\/doi.org\/10.1007\/s11419-022-00639-5","journal-title":"Forensic Toxicol"},{"issue":"3","key":"6569_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00213-018-5067-5","volume":"236","author":"JM Leyrer-Jackson","year":"2019","unstructured":"Leyrer-Jackson JM, Nagy EK, Olive MF (2019) Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation? Psychopharmacology 236(3):1079\u20131095. https:\/\/doi.org\/10.1007\/s00213-018-5067-5","journal-title":"Psychopharmacology"},{"issue":"1","key":"6569_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13049-017-0369-x","volume":"25","author":"E Liakoni","year":"2017","unstructured":"Liakoni E, M\u00fcller S, Stoller A, Ricklin M, Liechti ME, Exadaktylos AK (2017) Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity. Scand J Trauma Resusc Emerg Med 25(1):26. https:\/\/doi.org\/10.1186\/s13049-017-0369-x","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"6569_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/eip.13202","author":"L Lian","year":"2021","unstructured":"Lian L, Kim DD, Procyshyn RM, Fredrikson DH, C\u00e1zares D, Honer WG, Barr AM (2021) Efficacy of long-acting injectable versus oral antipsychotic drugs in early psychosis: A systematic review and meta-analysis. Early Interv Psychiatry. https:\/\/doi.org\/10.1111\/eip.13202","journal-title":"Early Interv Psychiatry"},{"issue":"2","key":"6569_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/jcp.0000000000001649","volume":"43","author":"CH Lin","year":"2023","unstructured":"Lin CH, Chen JJ, Chan CH (2023) Comparison of psychiatric and clinical profiles between people who use synthetic cathinones and methamphetamine: a matched case-control study. J Clin Psychopharmacol 43(2):122\u2013130. https:\/\/doi.org\/10.1097\/jcp.0000000000001649","journal-title":"J Clin Psychopharmacol"},{"key":"6569_CR52","doi-asserted-by":"publisher","unstructured":"Lo LA, MacCallum CA, Yau JC, Barr AM (2022) Differences in those who prefer smoking cannabis to other consumption forms for mental health: what can be learned to promote safer methods of consumption? J Addict Dis 1\u20135. https:\/\/doi.org\/10.1080\/10550887.2022.2107332","DOI":"10.1080\/10550887.2022.2107332"},{"issue":"3","key":"6569_CR53","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11920-006-0021-3","volume":"8","author":"BA Maher","year":"2006","unstructured":"Maher BA (2006) The relationship between delusions and hallucinations. Curr Psychiatry Rep 8(3):179\u2013183. https:\/\/doi.org\/10.1007\/s11920-006-0021-3","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"6569_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/14659890903075074","volume":"15","author":"G Martin","year":"2010","unstructured":"Martin G, Copeland J (2010) Brief intervention for regular ecstasy (MDMA) users: Pilot randomized trial of a Check-up model. J Subst Use 15(2):131\u2013142. https:\/\/doi.org\/10.3109\/14659890903075074","journal-title":"J Subst Use"},{"issue":"1","key":"6569_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/s1092852920001479","volume":"26","author":"G Martinotti","year":"2021","unstructured":"Martinotti G, De Risio L, Vannini C, Schifano F, Pettorruso M, Di Giannantonio M (2021) Substance-related exogenous psychosis: a postmodern syndrome. CNS Spectr 26(1):84\u201391. https:\/\/doi.org\/10.1017\/s1092852920001479","journal-title":"CNS Spectr"},{"issue":"8","key":"6569_CR56","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/add.14170","volume":"113","author":"R McKetin","year":"2018","unstructured":"McKetin R (2018) Methamphetamine psychosis: insights from the past. Addiction 113(8):1522\u20131527. https:\/\/doi.org\/10.1111\/add.14170","journal-title":"Addiction"},{"key":"6569_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnins.2016.00153","volume":"10","author":"C Miliano","year":"2016","unstructured":"Miliano C, Serpelloni G, Rimondo C, Mereu M, Marti M, De Luca MA (2016) Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants. Front Neurosci 10:153. https:\/\/doi.org\/10.3389\/fnins.2016.00153","journal-title":"Front Neurosci"},{"issue":"1","key":"6569_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13181-012-0243-1","volume":"9","author":"CM Murphy","year":"2013","unstructured":"Murphy CM, Dulaney AR, Beuhler MC, Kacinko S (2013) \u201cBath salts\u201d and \u201cplant food\u201d products: the experience of one regional US poison center. J Med Toxicol 9(1):42\u201348. https:\/\/doi.org\/10.1007\/s13181-012-0243-1","journal-title":"J Med Toxicol"},{"key":"6569_CR59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2017.06.018","volume":"124","author":"RM Murray","year":"2017","unstructured":"Murray RM, Englund A, Abi-Dargham A, Lewis DA, Di Forti M, Davies C, Sherif M, McGuire P, D\u2019Souza DC (2017) Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology 124:89\u2013104. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.018","journal-title":"Neuropharmacology"},{"issue":"1","key":"6569_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s13181-019-00749-4","volume":"16","author":"B Murray","year":"2020","unstructured":"Murray B, Carpenter J, Dunkley C, Moran TP, Kiernan EA, Rianprakaisang T, Alsukaiti WS, Calello DP, Kazzi Z (2020) Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol 16(1):12\u201316. https:\/\/doi.org\/10.1007\/s13181-019-00749-4","journal-title":"J Med Toxicol"},{"issue":"3","key":"6569_CR61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/schbul\/sbz102","volume":"46","author":"B Murrie","year":"2020","unstructured":"Murrie B, Lappin J, Large M, Sara G (2020) Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis. Schizophr Bull 46(3):505\u2013516. https:\/\/doi.org\/10.1093\/schbul\/sbz102","journal-title":"Schizophr Bull"},{"issue":"10","key":"6569_CR62","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1080\/10826084.2020.1753775","volume":"55","author":"M Ordak","year":"2020","unstructured":"Ordak M, Nasierowski T, Muszynska E, Bujalska-Zadrozny M (2020) The psychiatric characteristics of people on a mephedrone (\u201cbath salts\u201d) Binge. Subst Use Misuse 55(10):1610\u20131617. https:\/\/doi.org\/10.1080\/10826084.2020.1753775","journal-title":"Subst Use Misuse"},{"key":"6569_CR63","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fpsyt.2019.00851","volume":"10","author":"L Orsolini","year":"2019","unstructured":"Orsolini L, Chiappini S, Papanti D, De Berardis D, Corkery JM, Schifano F (2019) The bridge between classical and \u201csynthetic\u201d\/chemical psychoses: towards a clinical, psychopathological, and therapeutic perspective. Front Psychiatry 10:851. https:\/\/doi.org\/10.3389\/fpsyt.2019.00851","journal-title":"Front Psychiatry"},{"issue":"7","key":"6569_CR64","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0020764018801690","volume":"64","author":"MB Ortiz-Medina","year":"2018","unstructured":"Ortiz-Medina MB, Perea M, Torales J, Ventriglio A, Vitrani G, Aguilar L, Roncero C (2018) Cannabis consumption and psychosis or schizophrenia development. Int J Soc Psychiatry 64(7):690\u2013704. https:\/\/doi.org\/10.1177\/0020764018801690","journal-title":"Int J Soc Psychiatry"},{"issue":"1","key":"6569_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10(1):89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"6569_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.drugalcdep.2018.03.049","volume":"188","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Pollini RA (2018) Injection drug use, HIV\/HCV, and related services in nonurban areas of the United States: A systematic review. Drug Alcohol Depend 188:239\u2013250. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.049","journal-title":"Drug Alcohol Depend"},{"key":"6569_CR67","doi-asserted-by":"publisher","first-page":"110721","DOI":"10.1016\/j.forsciint.2021.110721","volume":"321","author":"LD Paul","year":"2021","unstructured":"Paul LD, Welter-Luedeke J, Penzel S, Zangl A, Graw M (2021) Alpha-Pyrrolidinopentiothiophenone (\u03b1-PVT): A forensic case study including plasma concentrations. Forensic Sci Int 321:110721. https:\/\/doi.org\/10.1016\/j.forsciint.2021.110721","journal-title":"Forensic Sci Int"},{"issue":"1","key":"6569_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.schres.2014.05.021","volume":"161","author":"BD Peters","year":"2015","unstructured":"Peters BD, Karlsgodt KH (2015) White matter development in the early stages of psychosis. Schizophr Res 161(1):61\u201369. https:\/\/doi.org\/10.1016\/j.schres.2014.05.021","journal-title":"Schizophr Res"},{"issue":"2\u20133","key":"6569_CR69","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.schres.2010.07.016","volume":"123","author":"RM Procyshyn","year":"2010","unstructured":"Procyshyn RM, Barr AM, Flynn S, Schenk C, Ganesan S, Honer WG (2010) Long-acting injectable risperidone in treatment refractory patients: a 14-week open-label pilot study. Schizophr Res 123(2\u20133):273\u2013275. https:\/\/doi.org\/10.1016\/j.schres.2010.07.016","journal-title":"Schizophr Res"},{"issue":"6","key":"6569_CR70","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2014.12.012","volume":"78","author":"A Ramos-Miguel","year":"2015","unstructured":"Ramos-Miguel A, Beasley CL, Dwork AJ, Mann JJ, Rosoklija G, Barr AM, Honer WG (2015) Increased SNARE protein-protein interactions in orbitofrontal and anterior cingulate cortices in Schizophrenia. Biol Psychiatry 78(6):361\u2013373. https:\/\/doi.org\/10.1016\/j.biopsych.2014.12.012","journal-title":"Biol Psychiatry"},{"key":"6569_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuroscience.2018.12.045","volume":"420","author":"A Ramos-Miguel","year":"2019","unstructured":"Ramos-Miguel A, Barakauskas V, Alamri J, Miyauchi M, Barr AM, Beasley CL, Rosoklija G, Mann JJ, Dwork AJ, Moradian A, Morin GB, Honer WG (2019) The SNAP25 interactome in ventromedial caudate in schizophrenia includes the mitochondrial protein ARF1. Neuroscience 420:97\u2013111. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.12.045","journal-title":"Neuroscience"},{"issue":"2","key":"6569_CR72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5195\/jmla.2021.962","volume":"109","author":"ML Rethlefsen","year":"2021","unstructured":"Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB (2021) PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews(). J Med Libr Assoc 109(2):174\u2013200. https:\/\/doi.org\/10.5195\/jmla.2021.962","journal-title":"J Med Libr Assoc"},{"issue":"Pt A","key":"6569_CR73","doi-asserted-by":"publisher","first-page":"109118","DOI":"10.1016\/j.drugalcdep.2021.109118","volume":"229","author":"V Ricci","year":"2021","unstructured":"Ricci V, Ceci F, Di Carlo F, Lalli A, Ciavoni L, Mosca A, Sepede G, Salone A, Quattrone D, Fraticelli S, Maina G, Martinotti G (2021) Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study. Drug Alcohol Depend 229(Pt A):109118. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109118","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"6569_CR74","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0092-6566(03)00067-9","volume":"38","author":"JW Roberti","year":"2004","unstructured":"Roberti JW (2004) A review of behavioral and biological correlates of sensation seeking. J Res Pers 38(3):256\u2013279. https:\/\/doi.org\/10.1016\/S0092-6566(03)00067-9","journal-title":"J Res Pers"},{"issue":"1","key":"6569_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/ADT.0b013e318285308d","volume":"13","author":"N Sadeg","year":"2014","unstructured":"Sadeg N, Darie A, Vilamot B, Passamar M, Frances B, Belhadj-Tahar H (2014) Case report of cathinone-like designer drug intoxication psychosis and addiction with serum identification. Addict Disord Treat 13(1):38\u201343. https:\/\/doi.org\/10.1097\/ADT.0b013e318285308d","journal-title":"Addict Disord Treat"},{"issue":"3","key":"6569_CR76","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bcp.14132","volume":"86","author":"F Schifano","year":"2020","unstructured":"Schifano F, Napoletano F, Arillotta D, Zangani C, Gilgar L, Guirguis A, Corkery JM, Vento A (2020) The clinical challenges of synthetic cathinones. Br J Clin Pharmacol 86(3):410\u2013419. https:\/\/doi.org\/10.1111\/bcp.14132","journal-title":"Br J Clin Pharmacol"},{"key":"6569_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fpsyt.2020.00705","volume":"11","author":"B Schreck","year":"2020","unstructured":"Schreck B, Guerlais M, Laforgue E, Bichon C, Grall-Bronnec M, Victorri-Vigneau C (2020) Cathinone use disorder in the context of slam practice: new pharmacological and clinical challenges. Front Psychiatry 11:705. https:\/\/doi.org\/10.3389\/fpsyt.2020.00705","journal-title":"Front Psychiatry"},{"issue":"2","key":"6569_CR78","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0193-953X(18)30053-4","volume":"18","author":"MJ Sedler","year":"1995","unstructured":"Sedler MJ (1995) Understanding delusions. Psychiatr Clin North Am 18(2):251\u2013262","journal-title":"Psychiatr Clin North Am"},{"key":"6569_CR79","doi-asserted-by":"publisher","unstructured":"Sim\u00e3o AY, Antunes M, Cabral E, Oliveira P, Rosendo LM, Brinca AT, Alves E, Marques H, Rosado T, Passarinha LA, Andraus M, Barroso M, Gallardo E (2022) An Update on the Implications of New Psychoactive Substances in Public Health. Int J Environ Res Public Health 19(8). https:\/\/doi.org\/10.3390\/ijerph19084869","DOI":"10.3390\/ijerph19084869"},{"issue":"6","key":"6569_CR80","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/15563650.2011.590812","volume":"49","author":"HA Spiller","year":"2011","unstructured":"Spiller HA, Ryan ML, Weston RG, Jansen J (2011) Clinical experience with and analytical confirmation of \u201cbath salts\u201d and \u201clegal highs\u201d (synthetic cathinones) in the United States. Clin Toxicol (phila) 49(6):499\u2013505. https:\/\/doi.org\/10.3109\/15563650.2011.590812","journal-title":"Clin Toxicol (phila)"},{"issue":"1","key":"6569_CR81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ppc.12101","volume":"52","author":"BM Stiles","year":"2016","unstructured":"Stiles BM, Fish AF, Cook CA, Silva V (2016) Bath salt-induced psychosis: nursing assessment, diagnosis, treatment, and outcomes. Perspect Psychiatr Care 52(1):68\u201378. https:\/\/doi.org\/10.1111\/ppc.12101","journal-title":"Perspect Psychiatr Care"},{"key":"6569_CR82","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2020) Treatment of Stimulant Use Disorders. Substance Abuse and Mental Health Services Administration"},{"issue":"2","key":"6569_CR83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15504263.2014.906133","volume":"10","author":"Y Tang","year":"2014","unstructured":"Tang Y, Martin NL, Cotes RO (2014) Cocaine-induced psychotic disorders: presentation, mechanism, and management. J Dual Diagn 10(2):98\u2013105. https:\/\/doi.org\/10.1080\/15504263.2014.906133","journal-title":"J Dual Diagn"},{"issue":"3","key":"6569_CR84","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7861\/clinmed.2020-0706","volume":"21","author":"M Tanti","year":"2021","unstructured":"Tanti M, Cosgrove J, Kelleher C, Jones R, Maguire M (2021) Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital. Clin Med (lond) 21(3):189\u2013194. https:\/\/doi.org\/10.7861\/clinmed.2020-0706","journal-title":"Clin Med (lond)"},{"key":"6569_CR85","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fpsyg.2015.00991","volume":"6","author":"D Telles-Correia","year":"2015","unstructured":"Telles-Correia D, Moreira AL, Gon\u00e7alves JS (2015) Hallucinations and related concepts-their conceptual background. Front Psychol 6:991. https:\/\/doi.org\/10.3389\/fpsyg.2015.00991","journal-title":"Front Psychol"},{"issue":"3","key":"6569_CR86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s13181-012-0232-4","volume":"8","author":"SL Thornton","year":"2012","unstructured":"Thornton SL, Gerona RR, Tomaszewski CA (2012) Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol 8(3):310\u2013313. https:\/\/doi.org\/10.1007\/s13181-012-0232-4","journal-title":"J Med Toxicol"},{"issue":"3","key":"6569_CR87","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/YIC.0000000000000014","volume":"29","author":"L Tse","year":"2014","unstructured":"Tse L, Procyshyn RM, Fredrikson DH, Boyda HN, Honer WG, Barr AM (2014) Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension. Int Clin Psychopharmacol 29(3):125\u2013137 (http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24169026)","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"6569_CR88","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/15563650.2016.1166508","volume":"54","author":"R Umebachi","year":"2016","unstructured":"Umebachi R, Aoki H, Sugita M, Taira T, Wakai S, Saito T, Inokuchi S (2016) Clinical characteristics of \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) poisoning. Clin Toxicol (phila) 54(7):563\u2013567. https:\/\/doi.org\/10.3109\/15563650.2016.1166508","journal-title":"Clin Toxicol (phila)"},{"key":"6569_CR89","unstructured":"United Nations Office of Drugs and Crime. (2022). Large seizures of synthetic cathinones in Europe reflect their growing importance on the illicit stimulants market UNODC EWA. Retrieved 2023 Aug 8 from https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/189e540f-515b-475a-b9d2-30b6868bb454"},{"issue":"3","key":"6569_CR90","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cpem.2017.07.009","volume":"18","author":"M Valento","year":"2017","unstructured":"Valento M, Lebin J (2017) Emerging drugs of abuse: synthetic cannabinoids, phenylethylamines (2C Drugs), and synthetic cathinones. Clin Pediatr Emerg Med 18(3):203\u2013211. https:\/\/doi.org\/10.1016\/j.cpem.2017.07.009","journal-title":"Clin Pediatr Emerg Med"},{"key":"6569_CR91","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12888-016-1002-7","volume":"16","author":"OM Vallersnes","year":"2016","unstructured":"Vallersnes OM, Dines AM, Wood DM, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Dargan PI (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:293. https:\/\/doi.org\/10.1186\/s12888-016-1002-7","journal-title":"BMC Psychiatry"},{"issue":"6","key":"6569_CR92","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00406-021-01337-w","volume":"272","author":"S Walther","year":"2022","unstructured":"Walther S, Lefebvre S, Conring F, Gangl N, Nadesalingam N, Alexaki D, W\u00fcthrich F, R\u00fcter M, Viher PV, Federspiel A, Wiest R, Stegmayer K (2022) Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia. Eur Arch Psychiatry Clin Neurosci 272(6):1021\u20131032. https:\/\/doi.org\/10.1007\/s00406-021-01337-w","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"6569_CR93","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annemergmed.2012.12.017","volume":"62","author":"BJ Warrick","year":"2013","unstructured":"Warrick BJ, Hill M, Hekman K, Christensen R, Goetz R, Casavant MJ, Wahl M, Mowry JB, Spiller H, Anderson D, Aleguas A, Gummin D, Thomas R, Nezlek C, Smolinske S (2013) A 9-state analysis of designer stimulant, \u201cbath salt,\u201d hospital visits reported to poison control centers. Ann Emerg Med 62(3):244\u2013251. https:\/\/doi.org\/10.1016\/j.annemergmed.2012.12.017","journal-title":"Ann Emerg Med"},{"key":"6569_CR94","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fpsyt.2018.00491","volume":"9","author":"TA Wearne","year":"2018","unstructured":"Wearne TA, Cornish JL (2018) A comparison of methamphetamine-induced psychosis and schizophrenia: a review of positive, negative, and cognitive symptomatology. Front Psychiatry 9:491. https:\/\/doi.org\/10.3389\/fpsyt.2018.00491","journal-title":"Front Psychiatry"},{"key":"6569_CR95","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fpsyt.2017.00156","volume":"8","author":"AM Weinstein","year":"2017","unstructured":"Weinstein AM, Rosca P, Fattore L, London ED (2017) Synthetic cathinone and cannabinoid designer drugs pose a major risk for public health. Front Psychiatry 8:156. https:\/\/doi.org\/10.3389\/fpsyt.2017.00156","journal-title":"Front Psychiatry"},{"issue":"12","key":"6569_CR96","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.jfma.2020.01.005","volume":"119","author":"TI Weng","year":"2020","unstructured":"Weng TI, Chen LY, Chen JY, Chen PS, Hwa HL, Fang CC (2020) Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. J Formos Med Assoc 119(12):1827\u20131834. https:\/\/doi.org\/10.1016\/j.jfma.2020.01.005","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"6569_CR97","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1080\/15563650.2022.2062376","volume":"60","author":"TI Weng","year":"2022","unstructured":"Weng TI, Chen HY, Chin LW, Chou HH, Wu MH, Chen GY, Chen JY, Shih CP, Lin CC, Fang CC (2022a) Comparison of clinical characteristics between meth\/amphetamine and synthetic cathinone users presented to the emergency department. Clin Toxicol (phila) 60(8):926\u2013932. https:\/\/doi.org\/10.1080\/15563650.2022.2062376","journal-title":"Clin Toxicol (phila)"},{"issue":"9","key":"6569_CR98","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.jfma.2022.03.007","volume":"121","author":"TI Weng","year":"2022","unstructured":"Weng TI, Chen LY, Chen HY, Yu JH, Su YJ, Liu SW, Tracy DK, Chen YC, Lin CC, Fang CC (2022b) Gender differences in clinical characteristics of emergency department patients involving illicit drugs use with analytical confirmation. J Formos Med Assoc 121(9):1832\u20131840. https:\/\/doi.org\/10.1016\/j.jfma.2022.03.007","journal-title":"J Formos Med Assoc"},{"issue":"11","key":"6569_CR99","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/jcph.742","volume":"56","author":"CM White","year":"2016","unstructured":"White CM (2016) Mephedrone and 3,4-methylenedioxypyrovalerone (MDPV): synthetic cathinones with serious health implications. J Clin Pharmacol 56(11):1319\u20131325. https:\/\/doi.org\/10.1002\/jcph.742","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"6569_CR100","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1176\/appi.ajp.161.3.480","volume":"161","author":"LM Williams","year":"2004","unstructured":"Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, Skerrett D, Phillips ML, David AS, Peduto A, Gordon E (2004) Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. Am J Psychiatry 161(3):480\u2013489. https:\/\/doi.org\/10.1176\/appi.ajp.161.3.480","journal-title":"Am J Psychiatry"},{"key":"6569_CR101","doi-asserted-by":"publisher","unstructured":"Yeh HT, Chen HY, Liu SW, Weng TI, Fang CC, Yu JH, Chen YC, Su YJ, Gao SY, Lin CC (2022) Clinical presentations and predictors of in-hospital mortality in illicit drug users in the new psychoactive substances (NPS) endemic era in Taiwan. Toxics 10(7). https:\/\/doi.org\/10.3390\/toxics10070386","DOI":"10.3390\/toxics10070386"},{"key":"6569_CR102","doi-asserted-by":"publisher","first-page":"609240","DOI":"10.3389\/fendo.2021.609240","volume":"12","author":"JWY Yuen","year":"2021","unstructured":"Yuen JWY, Kim DD, Procyshyn RM, Panenka WJ, Honer WG, Barr AM (2021) A focused review of the metabolic side-effects of clozapine. Front Endocrinol (lausanne) 12:609240. https:\/\/doi.org\/10.3389\/fendo.2021.609240","journal-title":"Front Endocrinol (lausanne)"},{"issue":"11","key":"6569_CR103","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoto.2022.2847","volume":"148","author":"S Zhou","year":"2022","unstructured":"Zhou S, Shen C (2022) Avoiding definitive conclusions in meta-analysis of heterogeneous studies with small sample sizes. JAMA Otolaryngol Head Neck Surg 148(11):1003\u20131004. https:\/\/doi.org\/10.1001\/jamaoto.2022.2847","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"6569_CR104","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/02791072.2019.1571652","volume":"51","author":"L Zimmerman","year":"2019","unstructured":"Zimmerman L, Kilwein TM, Beyer D, Marks C, Looby A (2019) \u201cNot for Human Consumption\u201d: A descriptive investigation into user characteristics, motives, and consequences associated with bath salt use. J Psychoactive Drugs 51(3):218\u2013224. https:\/\/doi.org\/10.1080\/02791072.2019.1571652","journal-title":"J Psychoactive Drugs"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06569-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T19:03:00Z","timestamp":1713553380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6569"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06569-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors state no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}